Corporate Banner
Satellite Banner
Technology Networks Header
Friday, August 29, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New Metrohm Brochure and Website Pharmaceutical Analysis
Tuesday, April 08, 2014
Metrohm’s new brochure Pharmaceutical analysis is a highly valuable compendium to get an overall view of the most important parameters determining the quality of pharmaceuticals and the methods best suited to check them.

Advancing High-Content Analysis for Cancer Applications
Tuesday, April 08, 2014
A new high-content screening software platform enables cancer researchers to uncover more about basic and advanced cellular function to accelerate cell-based research.

Tempo Bioscience Launches Human Cellular and Biosensor Products
Tuesday, April 08, 2014
Tempo Bioscience Inc announces the launch of its central nervous system (CNS) product line of human cell types for in vitro research and development (R&D) and chemical testing.

InSphero to Distribute Dainippon Screen Imager for Rapid Profiling of 3D Microtissues
Tuesday, April 08, 2014
The Cell'iMager, to be marketed in the US and Europe, simplifies growth and morphological profiling of 3D microtissues.

MultiFlo™ FX Multi-Mode Dispenser from BioTek
Saturday, April 05, 2014
MultiFlo FX with RAD™ technology expands capabilities.

Metabolon Launches Fourth Generation DiscoveryHD4™ Metabolomics Platform
Saturday, April 05, 2014
New technology advancements have potential to lead the way to new scientific breakthroughs, novel biomarkers and discoveries, and support diagnostic product pipeline.

New Application of TAP’s Automated Cell Culture System at AACR
Saturday, April 05, 2014
Offers rapid production and consistent quality of NCI 60 cancer cell line panel.

Newborn Screening Solution from AB SCIEX
Friday, April 04, 2014
Solution provides early detection indicators of metabolic disorders, helping doctors in Europe make babies’ health more predictable.

Cancer Genetics Expands BioDiscovery's Nexus Copy Number Platform
Thursday, April 03, 2014
Expansion to identify novel biomarkers predictive of cancer outcomes.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 2558
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.

Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv